Branded Legacy and Novus Partner to Develop
Plant-Based Meds for Health Plans
Melbourne, FL -- September 12, 2023 -- InvestorsHub
NewsWire -- Branded Legacy, Inc (OTC.PK:
BLEG), an emerging biotechnology company, is excited to
announce a strategic partnership with Novus Acquisition &
Development Corp (OTC.PK:
NDEV), a national supplemental health insurance carrier that is
a pioneer in offering cannabis-embedded health plans for both
recreational and medical use. This collaboration marks a
significant milestone in Branded
Legacy's mission to revolutionize the biotechnology landscape
while creating a profound impact on the healthcare industry.
The collaboration will entail Novus's expansive distribution
network of dispensaries across the United States. It will serve as
a distributor, promoting Branded Legacy's formularies to their
policyholders and those within health carriers that incorporate
Novus benefit packages.
The deal will entail the
following:
Point of Sale Integration: Novus will seamlessly
integrate Legacy Brands' formularies into dispensaries and
healthcare facilities'. This ensures policyholders can easily
access Legacy's prescriptions when visiting these locations.
Dual Role as Pharmacy Benefits Manager and Health
Carrier: Making Novus a key player in distributing
Legacy's formularies to policyholders at the point of sale and
wholesale level. This partnership has the potential to enhance the
availability and affordability of proprietary cannabis-based
treatments significantly.
David
Oswald, CEO of Branded Legacy, said; "That the collaboration
with Novus is a significant milestone in our mission to develop
proprietary formularies tailored to both companies' needs and based
on data identifying the most profitable products".
Frank
Labrozzi, CEO of Novus, commented, "The collaboration between
health insurance and biotech has been fruitful over the years, and
this partnership is no exception. Our objective is to provide
Branded Legacy well-researched cannabis-based formularies to
Americans, offering them more effective and affordable treatment
options."
The winds of change are happening; cannabis legalization is
advancing, unlocking fresh and inventive avenues for research. As
legal barriers shift, researchers now have a distinctive
opportunity to delve into this plant's medical, therapeutic, and
economic possibilities. This wave of transformation holds the
promise of thrilling discoveries that could reshape various
industries.
Branded Legacy looks forward to working closely with Novus to bring
innovative therapies and solutions to patients while creating
long-term value for stakeholders.
About Branded Legacy
Branded Legacy Inc. (OTC.PK:
BLEG),
is a forward-thinking biotechnology company committed to driving
innovation in plant-derived medicines and biotechnological
breakthroughs. The company's strategic partnerships and milestone
achievements highlight its dedication to transforming patient care
and contributing to the advancement of healthcare solutions.
About Novus Acquisition & Development
Corp.
Novus Acquisition & Development Corp. (NDEV)
functions via its subsidiary, WCIG Insurance Services,Inc. which
operates as a health insurance carrier. It offers health insurance
policies incorporating medical cannabis benefits alongside various
insurance offerings, such as supplemental health, life, and fixed
annuities. These medical plans are available in 35 states where
medical marijuana programs are legally established.
Novus
Website
For further updates on the Branded Legacy-Novus partnership and
upcoming developments, please visit the company's website at
brandedlegacy.com or contact them at INFO@BrandedLegacy.com
Media Contact
Joe Holladay
Branded Legacy
Phone: 321-345-3565
Email: info@brandedlegacy.com
Website: https://brandedlegacy.com/
Safe Harbor Statement on Forward-Looking
Language:
This release includes forward-looking statements, which are based
on certain assumptions and reflect management's current
expectations. These forward-looking statements are subject to a
number of risks and uncertainties that could cause actual results
or events to differ materially from current expectations. Some of
these factors include general global economic conditions; general
industry and market conditions and growth rates; uncertainty as to
whether our strategies and business plans will yield the expected
benefits; increasing competition; availability and cost of capital;
the ability to identify and develop and achieve commercial success;
the level of expenditures necessary to maintain and improve the
quality of services; changes in the economy; changes in laws and
regulations, includes codes and standards, intellectual property
rights, and tax matters; or other matters not anticipated; our
ability to secure and maintain strategic relationships and
distribution agreements. Dilution, if any, would be for the
purposes of management taking stock in lieu of cash salary. The
company disclaims any intention or obligation to update or revise
any forward-looking statements, whether as a result of new
information, future events, or otherwise. Additionally, this press
release that is not statements of historical fact may be considered
to be forward-looking statements. Written words such as "may,"
"will," "expect," "believe," "anticipate," "estimate," "intends,"
"goal," "objective," "seek," "attempt," or variations of these or
similar words, identify forward-looking statements. By their
nature, forward-looking statements and forecasts involve risks and
uncertainties because they relate to events and depend on
circumstances that will occur in the near future.